可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Mathers CD,Loncar D.Projections of global mortality and burden of disease from 2002 to 2030[J]. PLoS Med,2006,3(11):e442.
[2]Scott IA,Derhy PH,O’Kane D,et al.Discordance between level of risk and intensity of evidence-based treatment in patients with acute coronary syndromes[J].Med J Aust,2007,187(3):153-159.
[3]Zernecke A,Shagdarsuren E,Weber C,et al.Chemokines in atherosclerosis:an update[J].Arterioscler Thromb Vasc Biol,2008,28(11):1897-1908.
[4] Bursill CA,Channon KM,Greaves DR,et al.The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics[J].Curr Opin Lipidol,2004,15(2):145-149.
[5]Vogiatzi K,Apostolakis S,Voudris V,et al.Interleukin 8 and susceptibility to coronary artery disease:a population genetics perspective[J].J Clin Immunol,2008,28(4):329-335.
[6]Rigamonti E,Fontaine C,Lefebvre B,et al.Induction of CXCR2 receptor by peroxisome proliferator-activated receptor gamma in human macrophages[J].Arterioscler Thromb Vasc Biol,2008,28(5):932-939.
[7]Boisvert WA,Curtiss LK,Terkeltaub RA.Interleukin-8 and its receptor CXCR2 in atherosclerosis[J].Immunol Res,2000,21(2-3):129-137.
[8]Simonini A, Moscucci M,Muller DW,et al.IL-8 is an angiogenic factor in human coronary atherectomy[J].Tissue, 2000,101(13):1519-1526.
[9]Qi X,Peng Y,Gu J,et al.Inflammatory cytokine release in patients with unstable angina after coronary angioplasty[J].Jpn Heart J,2002,43(3):103-115.
[10]Henriques de Gouveia R,van der Wal AC,van der Loos CM,et al.Sudden unexpected death in young adults.Discrepancies between initiation of acute plaque complications and the onset of acute coronary death[J].Eur Heart J,2002,23(18):1433-1440.
[11]Zhang L,Li HY,Li H,et al. Lipopolysaccharide activated phosphatidy lc holine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells[J].J Cell Physiol,2011,226(6):1694-1701.
[12]Szomjak E,Der H,Kerekes G,et al.Immunological parameters,including CXCL8 (IL-8) characterize cerebro- and cardiovascular events in patients with peripheral artery diseases[J].Clinical Immunology,2010,71(4):283-291.